Mio Yanagisawa

Mio Yanagisawa practices at Piedmont Physicians of Mountainside in Fayetteville, Georgia.

Mio Yanagisawa's NPI, 1376955831, was assigned on June 2, 2014. Mio Yanagisawa graduated from University of Texas Southwestern Medical School at Dallas in 2014. Mio Yanagisawa holds Georgia license 85457.

Mio Yanagisawa's primary practice is Piedmont Physicians of Mountainside, at 1279 Highway 54 W, Fayetteville, GA 30214 in Fayette County. The practice phone is (770) 801-2500.

Mio Yanagisawa's primary practice is Piedmont Physicians of Mountainside in Fayetteville, Georgia. Mio Yanagisawa is also affiliated with Piedmont Fayette Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Mio Yanagisawa to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mio Yanagisawa practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Mio Yanagisawa's primary specialty in the NPI Registry, under taxonomy code 208600000X. Mio Yanagisawa is licensed in Georgia.

CMS data shows 388 Medicare services from Mio Yanagisawa across 11 procedure codes in 2024, for 191 Medicare patients. Medicare paid $57,145 for them.

CMS counts 191 Medicare patients who saw Mio Yanagisawa in 2024. The largest group is 65 to 74, with 101 patients. 74% of them have high cholesterol, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mio Yanagisawa's median patient age at 57, with 97% women.

In 2024, Mio Yanagisawa wrote 225 Medicare Part D claims for 96 patients. 100% of them were for generic drugs. CMS names the drug for 148 of them, across 5 drugs with 11 or more claims each, at $584 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Mio Yanagisawa for performance year 2024, reported through an alternative payment model (APM). Mio Yanagisawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of mastectomy by Mio Yanagisawa, more than 94% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 56 general payments to Mio Yanagisawa from 19 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $463.

Mio Yanagisawa graduated from University of Texas Southwestern Medical School at Dallas in 2014.